Page last updated: 2024-08-16

temozolomide and nsc 664704

temozolomide has been researched along with nsc 664704 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domoto, T; Dong, Y; Furuta, T; Hayashi, Y; Hirao, A; Jiapaer, S; Kitabayashi, T; Kobayashi, M; Minamoto, T; Nakada, M; Sabit, H; Zhang, G; Zhang, J	1

Other Studies

1 other study(ies) available for temozolomide and nsc 664704

Article	Year
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma. Scientific reports, 2019, 07-11, Volume: 9, Issue:1 Topics: Animals; Benzazepines; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glioblastoma; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinases; Humans; Indoles; Mice; Neoplastic Stem Cells; Protein Kinase Inhibitors; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays	2019

Article

Year

Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma.

Scientific reports, 2019, 07-11, Volume: 9, Issue:1

Topics: Animals; Benzazepines; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glioblastoma; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinases; Humans; Indoles; Mice; Neoplastic Stem Cells; Protein Kinase Inhibitors; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays

2019